Medication Errors From Over-the-Counter Cough and Cold Medications in Children.


Journal

Academic pediatrics
ISSN: 1876-2867
Titre abrégé: Acad Pediatr
Pays: United States
ID NLM: 101499145

Informations de publication

Date de publication:
04 2020
Historique:
received: 30 04 2019
revised: 14 09 2019
accepted: 22 09 2019
pubmed: 29 9 2019
medline: 18 3 2021
entrez: 29 9 2019
Statut: ppublish

Résumé

Out of hospital medication-related adverse events (AEs) from cough and cold medications (CCMs) can have significant public health impact. The objective of this study was to characterize pediatric medication error AEs involving over-the-counter (OTC) CCMs to identify preventable factors. Multisource national data surveillance system study using an expert panel evaluating CCM AEs related to medication errors. age <12 years, and at least 1 significant AE from at least 1 index ingredient from a CCM OTC product. From 2009 through 2016, 4756 cases were determined to have a significant AE related to an OTC CCM ingredient and 513 (10.8%) cases were due to a medication error. Nearly half of medication errors involved children 2 to <6 years old (n = 235; 45.8%). Many involved administration by a parent (n = 231; 45.0%) or alternative caregiver (n = 148; 28.8%). In nearly all cases (93.2%), the medication error involved the wrong dose of the medication. Health care facility evaluation occurred in 381 (74.3%) cases. Diphenhydramine and dextromethorphan were responsible for most medication errors and medication errors involving health care facility evaluation. There were no deaths from medication errors. In this multiyear surveillance study, medication errors most commonly occurred in children <6 years old who received the wrong volume of a liquid product. Diphenhydramine and dextromethorphan dosing errors were the most common cause of medication errors resulting from CCM use. Continued standardization of measuring devices, concentrations, and units of measure along with consumer education are needed to further decrease medication errors from CCMs.

Identifiants

pubmed: 31562931
pii: S1876-2859(19)30389-4
doi: 10.1016/j.acap.2019.09.006
pii:
doi:

Substances chimiques

Nonprescription Drugs 0
Dextromethorphan 7355X3ROTS
Diphenhydramine 8GTS82S83M

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-332

Informations de copyright

Published by Elsevier Inc.

Auteurs

George Sam Wang (GS)

Department of Pediatrics, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus (GS Wang), Aurora, Colo; Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority (GS Wang, KM Reynolds, RB Palmer, M Rapp-Olsson, JL Green, and RC Dart), Denver, Colo.

Kate M Reynolds (KM)

Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority (GS Wang, KM Reynolds, RB Palmer, M Rapp-Olsson, JL Green, and RC Dart), Denver, Colo. Electronic address: kate.reynolds@rmpds.org.

William Banner (W)

Oklahoma Center for Poison and Drug Information, Oklahoma University College of Pharmacy (W Banner), Oklahoma City, Okla.

G Randall Bond (GR)

Faculté de Médecine, Hope Africa University (GR Bond), Bujumbura, Burundi.

Ralph E Kauffman (RE)

Department of Pediatrics, University of Missouri-Kansas City School of Medicine (RE Kauffman), Kansas City, Mo.

Robert B Palmer (RB)

Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority (GS Wang, KM Reynolds, RB Palmer, M Rapp-Olsson, JL Green, and RC Dart), Denver, Colo.

Ian M Paul (IM)

Pediatrics & Public Health Sciences, Penn State College of Medicine (IM Paul), Hershey, Pa.

Malin Rapp-Olsson (M)

Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority (GS Wang, KM Reynolds, RB Palmer, M Rapp-Olsson, JL Green, and RC Dart), Denver, Colo.

Jody L Green (JL)

Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority (GS Wang, KM Reynolds, RB Palmer, M Rapp-Olsson, JL Green, and RC Dart), Denver, Colo; Inflexion, an IBH Company (JL Green), Costa Mesa, Calif.

Richard C Dart (RC)

Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority (GS Wang, KM Reynolds, RB Palmer, M Rapp-Olsson, JL Green, and RC Dart), Denver, Colo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH